325 related articles for article (PubMed ID: 18239407)
1. Pregnancy and breastfeeding in patients with Crohn's disease.
Mottet C; Juillerat P; Pittet V; Gonvers JJ; Froehlich F; Vader JP; Michetti P; Felley C
Digestion; 2007; 76(2):149-60. PubMed ID: 18239407
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy and Crohn's disease.
Mottet C; Juillerat P; Gonvers JJ; Froehlich F; Burnand B; Vader JP; Michetti P; Felley C
Digestion; 2005; 71(1):54-61. PubMed ID: 15711051
[TBL] [Abstract][Full Text] [Related]
3. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
4. [Drug treatment of Crohn's disease].
van Deventer SJ; Tytgat GN
Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
[TBL] [Abstract][Full Text] [Related]
5. Review article: chronic active disease and maintaining remission in Crohn's disease.
Kamm MA
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
[TBL] [Abstract][Full Text] [Related]
6. Medical therapy and birth outcomes in women with Crohn's disease: what should we tell our patients?
Friedman S
Am J Gastroenterol; 2007 Jul; 102(7):1414-6. PubMed ID: 17593158
[TBL] [Abstract][Full Text] [Related]
7. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG; Sandborn WJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
[TBL] [Abstract][Full Text] [Related]
8. Medical therapy to reduce postoperative Crohn's disease recurrence.
Achkar JP; Hanauer SB
Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318
[TBL] [Abstract][Full Text] [Related]
9. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
Sandborn WJ; Feagan BG; Lichtenstein GR
Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease: management issues during pregnancy.
Ferrero S; Ragni N
Arch Gynecol Obstet; 2004 Sep; 270(2):79-85. PubMed ID: 12721680
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
Nørgård B; Pedersen L; Christensen LA; Sørensen HT
Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
[TBL] [Abstract][Full Text] [Related]
12. Drug safety in Crohn's disease therapy.
Juillerat P; Pittet V; Felley C; Mottet C; Froehlich F; Vader JP; Gonvers JJ; Michetti P
Digestion; 2007; 76(2):161-8. PubMed ID: 18239408
[TBL] [Abstract][Full Text] [Related]
13. Update on pregnancy and breastfeeding in the era of biologics.
Yarur A; Kane SV
Dig Liver Dis; 2013 Oct; 45(10):787-94. PubMed ID: 23474350
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of medically induced remission of Crohn's disease.
Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
[TBL] [Abstract][Full Text] [Related]
15. Managing the glucocorticoid dependent inflammatory bowel disease patient.
Bonner GF
Semin Gastrointest Dis; 2001 Oct; 12(4):237-44. PubMed ID: 11726077
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
17. Management of inflammatory bowel disease during pregnancy and nursing.
Friedman S
Semin Gastrointest Dis; 2001 Oct; 12(4):245-52. PubMed ID: 11726078
[TBL] [Abstract][Full Text] [Related]
18. [Pregnancy outcome in inflammatory bowel diseases].
Tennenbaum R; Marteau P; Elefant E; Rambaud JC; Modigliani R; Gendre JP; Cosnes J
Gastroenterol Clin Biol; 1999 May; 23(5):464-9. PubMed ID: 10429848
[TBL] [Abstract][Full Text] [Related]
19. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
[No Abstract] [Full Text] [Related]
20. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Feagan BG
Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
